:
The severe acute respiratory syndrome (SARS) is a critical respiratory disease caused by coronaviruses (CoV).
The available antiviral agents or host-specific anti-inflammatory therapies are the principal treatment modalities, with drugrepurposing as the most viable approach to timely tackle the CoV pandemic. Though these approaches are successful to
some extent in reducing the mortality rate, however, it is too far to see a complete escape from the current CoV-2 pandemic.
Plants are the primary source of diet, dietary supplements, botanical drugs, and natural products (NPs). It has been well accepted and proved via several scientific studies that plant-based therapies play a vital role in protecting against such infections. The faulty immune system (compromised innate immunity or aberrant immune activation) decides the severity of the
respiratory distress in CoV-2 infected patients. Natural products intervene at various stages of the virus replication cycle, including inhibition of virus entry into the host cells, inhibition of serine/ cysteine proteases, RNA-dependent RNA polymerase (RdRp) or helicase. Besides, several natural products or plant-based dietary ingredients have a unique ability to strengthen the immune system or alleviate the hyper-inflammatory condition. Many plant-based formulations, dietary supplements,
and NPs are being investigated in clinical trials in CoV-2 patients, and few have already shown positive results. The review
has unearthed several NP leads for medicinal chemistry programs as well as some having direct opportunity of repurposing
in SARS CoV infections.
Chronic Inflammation: Prospective Prevention and/or Control by the Regulation of Nuclear Factor Kappa B with Natural Products as Dietary Supplements
